T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
OneSpan
OSPN
$609M
| $624K | ﹤0.01% |
25,460
-7,744
| -23% | -$190K |
|
2252
Pembina Pipeline
PBA
$28.4B
| $623K | ﹤0.01% |
21,569
+32
| +0.1% | +$889 |
|
|
RVNC
2253
DELISTED
Revance Therapeutics, Inc.
RVNC
| $622K | ﹤0.01% |
22,242
-6,904
| -24% | -$191K |
|
|
AGR
2254
DELISTED
Avangrid, Inc.
AGR
| $621K | ﹤0.01% |
12,465
+3,819
| +44% | +$179K |
|
2255
Ezcorp Inc
EZPW
$1.78B
| $620K | ﹤0.01% |
124,670
+8,181
| +7% | +$41.1K |
|
2256
LeMaitre Vascular
LMAT
$1.87B
| $620K | ﹤0.01% |
12,700
-18
| -0.1% | -$844 |
|
|
SPTN
2257
DELISTED
SpartanNash
SPTN
| $619K | ﹤0.01% |
31,518
+10,259
| +48% | +$194K |
|
|
ECHO
2258
EchoStar
ECHO
$26.6B
| $618K | ﹤0.01% |
25,751
+9,406
| +58% | +$225K |
|
|
RDS.A
2259
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $618K | ﹤0.01% |
15,750
| – | – |
|
2260
Center Bancorp
CNOB
$1.81B
| $616K | ﹤0.01% |
24,289
-63
| -0.3% | -$1.48K |
|
2261
FuboTV Inc
FUBO
$293M
| $615K | ﹤0.01% |
2,317
+450
| +24% | +$193K |
|
|
LGF.B
2262
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $615K | ﹤0.01% |
47,641
+708
| +2% | +$9.32K |
|
|
PRSU
2263
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $614K | ﹤0.01% |
14,704
-2,405
| -14% | -$95.4K |
|
2264
Calix
CALX
$2.51B
| $613K | ﹤0.01% |
17,681
+8,013
| +83% | +$297K |
|
2265
Kopin
KOPN
$898M
| $613K | ﹤0.01% |
+58,400
| New | +$442K |
|
|
ZOM
2266
DELISTED
Zomedica Corp.
ZOM
| $613K | ﹤0.01% |
+387,800
| New | +$634K |
|
2267
Collegium Pharmaceutical
COLL
$913M
| $612K | ﹤0.01% |
25,805
+4,832
| +23% | +$115K |
|
|
SCS
2268
DELISTED
Steelcase
SCS
| $612K | ﹤0.01% |
42,527
-6,084
| -13% | -$86.2K |
|
2269
Goosehead Insurance
GSHD
$2.33B
| $610K | ﹤0.01% |
5,690
-3,600
| -39% | -$487K |
|
2270
Tompkins Financial
TMP
$1.44B
| $610K | ﹤0.01% |
7,374
-1,380
| -16% | -$109K |
|
2271
First Interstate BancSystem
FIBK
$3.7B
| $609K | ﹤0.01% |
13,232
-4,901
| -27% | -$218K |
|
|
ZGNX
2272
DELISTED
Zogenix, Inc.
ZGNX
| $607K | ﹤0.01% |
31,095
+28
| +0.1% | +$574 |
|
2273
Omeros
OMER
$1.26B
| $606K | ﹤0.01% |
34,046
+15
| +0% | +$292 |
|
2274
Bilibili
BILI
$7.14B
| $604K | ﹤0.01% |
+5,645
| New | +$690K |
|
2275
Lexicon Pharmaceuticals
LXRX
$1.04B
| $604K | ﹤0.01% |
102,931
-77,144
| -43% | -$534K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.